GlassScriptPhysician profile
Aneeta J Gupta
NPI 1659370005
$12,231.61
in general payments reported to CMS, 2019-2025
69 companies · $2,156 in 2025
The $2,156 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,846 · 2020: $787 · 2021: $905 · 2022: $1,460 · 2023: $3,284 · 2024: $1,795 · 2025: $2,156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,976 · Travel and Lodging: $1,070 · Education: $188.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,976.06 |
| Travel and Lodging | $1,070.25 |
| Education | $187.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $1,618.61 | 2022-2023 | Vns Therapy |
| Teva Pharmaceuticals USA, INC. | $1,418.74 | 2019-2025 | Austedo Xr, Ajovy, Austedo Xr |
| Novartis Pharmaceuticals Corporation | $845.44 | 2019-2025 | |
| Biogen, INC. | $692.35 | 2019-2025 | Vumerity, Tysabri, Tecfidera |
| Alexion Pharmaceuticals, INC. | $586.72 | 2019-2025 | Ultomiris, Soliris |
| Abbvie INC. | $523.70 | 2022-2025 | |
| Lilly USA, LLC | $522.88 | 2019-2024 | Emgality, Reyvow, Amyvid |
| Eisai INC. | $411.10 | 2019-2025 | |
| Ucb, INC. | $361.13 | 2019-2025 | Rystiggo, Nayzilam, Briviact |
| Pfizer INC. | $283.92 | 2024-2025 | |
| Janssen Pharmaceuticals, INC | $280.95 | 2021-2022 | |
| Mdd US Operations, LLC | $273.60 | 2019-2025 | Xadago, Apokyn, Gocovri |
| Sk Life Science, INC. | $216.42 | 2021-2025 | |
| Amneal Pharmaceuticals LLC | $213.17 | 2019-2025 | Crexont, Rytary |
| Argenx US, INC. | $210.88 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
Show all 69 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aneeta Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.